Neogen Chemicals to attend analyst meet on Jun 23

1 min read Updated on 13 Jun 2026, 04:50 AM

Reviewed by

Naman SScanX News Team

AI Summary

Neogen Chemicals Limited management will participate in an analyst and investor group meeting on June 23, 2026, at Grand Hyatt, Mumbai. The meeting, organized by PhillipCapital, will discuss the company's business overview, financial performance, and outlook. No unpublished price sensitive information will be shared.

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited management will participate in an analyst and investor group meeting on June 23, 2026, to discuss its business overview, financial performance, and outlook. The meeting, titled India Inc. Unplugged by PhillipCapital - Private Client Group, is scheduled to take place at Grand Hyatt, Mumbai. The session will feature a mix of 1x1 and group meetings, providing a platform for engagement with the investment community.

The participation is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has clarified that no unpublished price sensitive information will be shared during the meeting. Additionally, the company noted that the date and participants of the meet are subject to change due to exigencies on the part of organizers, investors, analysts, or the company.

Date of Meeting	Meeting	Place	Mode of Meeting
June 23, 2026	India Inc. Unplugged by PhillipCapital - Private Client Group	Grand Hyatt, Mumbai	Mix of 1x1 and group meetings

Further details regarding the meeting have been uploaded on the company’s website. The intimation was submitted by Unnati Kanani, Company Secretary & Compliance Officer of Neogen Chemicals Limited.

Historical Stock Returns for Neogen Chemicals

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.25%	+8.01%	+16.75%	+84.75%	+17.39%	+132.58%

What strategic growth areas is Neogen Chemicals likely to emphasize during the meeting?

How might the discussions influence investor sentiment regarding Neogen's financial outlook?

Could the meeting reveal any upcoming partnerships or expansion plans?

Read Next Article

Axis Mutual Fund reduces stake in Neogen Chemicals to 4.04%

1 min read Updated on 05 Jun 2026, 04:16 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

AI Summary

Axis Mutual Fund reduced its stake in Neogen Chemicals by 1.46% on June 2, 2026, via the sale of 4,00,000 shares. The disposal, executed by the Axis Small Cap Fund, lowered the total holding to 4.04% of the paid-up share capital. The transaction was part of ordinary portfolio rebalancing and disclosed to BSE and NSE.

*this image is generated using AI for illustrative purposes only.

Axis Mutual Fund has reduced its shareholding in Neogen Chemicals by 1.46% through an open market disposal on June 2, 2026. This transaction lowers the fund's total equity stake in the company to 4.04%, complying with disclosure requirements under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The sale comprised 4,00,000 equity shares, executed by the Axis Small Cap Fund. Prior to this disposal, the mutual fund schemes collectively held 15,05,406 shares, representing 5.50% of the paid-up share capital. The reduction brings the total holding down to 11,05,406 shares. The equity share capital of Neogen Chemicals remains at Rs 27,38,16,740, comprising 2,73,81,674 shares of face value Rs 10.

Axis Asset Management Company Limited, the investment manager for Axis Mutual Fund, confirmed that the sale was conducted in the ordinary course of business as portfolio investments. The disclosure was submitted to the stock exchanges on June 3, 2026, and subsequently disseminated on June 5, 2026.

Scheme-wise Holdings

The following table details the shift in holdings across specific Axis Mutual Fund schemes before and after the disposal:

Scheme Name	Holding Before Disposal	Holding After Disposal
Axis Small Cap Fund	12,09,854 shares (4.42%)	18,370 shares (0.07%)
Axis Flexi Cap Fund	2,03,981 shares (0.74%)	–
Axis Innovation Fund	73,201 shares (0.27%)	–
Axis Children's Fund	18,370 shares (0.07%)	–
Axis Business Cycles Fund	–	8,09,854 shares (2.96%)
Axis Multicap Fund	–	2,03,981 shares (0.74%)
Axis ELSS Tax Saver Fund	–	73,201 shares (0.27%)
Total	15,05,406 shares (5.50%)	11,05,406 shares (4.04%)

The filing was signed by Unnati Rajesh Kanani, Company Secretary and Compliance Officer for Neogen Chemicals, and Darshan Kapadia, Compliance Officer for Axis Asset Management Company Limited.

Historical Stock Returns for Neogen Chemicals

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.25%	+8.01%	+16.75%	+84.75%	+17.39%	+132.58%

What prompted the strategic reallocation of Neogen Chemicals' shares from the Small Cap and Flexi Cap funds to the Business Cycles and Multicap funds?

How might this significant reduction in stake by a major institutional investor impact Neogen Chemicals' stock price and market sentiment in the short term?

Does this move signal a shift in Axis Mutual Fund's outlook on the chemical sector or Neogen Chemicals' growth potential?